Clinical Report: Creation and validation of a nomogram for Meige syndrome
Overview
This study developed and validated a nomogram to predict 1-year recurrence after radiofrequency ablation in patients with Meige syndrome. Key independent factors influencing recurrence included the Jankovic Rating score, disease duration, and final temperature.
Background
Meige syndrome is a rare cranial dystonia characterized by blepharospasm and oromandibular dystonia, primarily affecting individuals aged 40 to 70 years. Current treatment options include oral medications, botulinum toxin injections, and surgical interventions, with radiofrequency ablation emerging as a therapeutic option. Recurrence remains a significant concern.
Data Highlights
Factor
Influence on Recurrence
Jankovic Rating Score (JRS)
Independent predictor
Disease Duration
Independent predictor
Final Temperature
Independent predictor
AUC for Nomogram
0.932 (95% CI: 0.912–0.958)
Key Findings
A nomogram was developed to predict 1-year recurrence after radiofrequency ablation in Meige syndrome patients.
Independent factors influencing recurrence include the Jankovic Rating score, disease duration, and final temperature.
The nomogram demonstrated an AUC of 0.932, indicating high accuracy.
Calibration curves showed excellent agreement between predicted probabilities and actual observed values.
Decision curve analysis indicated a higher net benefit for the nomogram predictive model.
Clinical Implications
The nomogram can assist clinicians in identifying high-risk patients for postoperative recurrence.
Conclusion
The study constructed a nomogram for recurrence in Meige syndrome patients post-ablation.
